KDM5B expression is significantly up-regulated in bladder cancer, acute myelogenous leukemia, breast cancer, chronic myelogenous leukemia, cervical cancer and renal cell carcinoma compared with corresponding non-neoplastic tissues, indicating its involvement in many types of human cancer [8]. Here, KDM5B is linked to breast cancer.